Skip to content
Menu

West Pharmaceutical Servs Raises FY2026 GAAP EPS Guidance from $9.01-$9.26 to $9.31-$9.41 vs $8.47 Est

Benzinga Newsdesk 3 weeks ago

NewsGuidance

This page contains a summary, not the full article. Continue to benzinga.com to read the original report.

West Pharmaceutical Servs (NYSE:WST) raises FY2026 GAAP EPS guidance from $9.01-$9.26 to $9.31-$9.41 vs $8.47 analyst estimate..

West Pharmaceutical Servs (NYSE:WST) raises FY2026 GAAP EPS guidance from $9.01-$9.26 to $9.31-$9.41 vs $8.47 analyst estimate..

Read at benzinga.com

← All stock news